RxSight, Inc. (NASDAQ: RXST) is a Healthcare company (Medical - Devices) with a market capitalization of $203M. The Maz Rating grades it against the other companies in its sector.
RxSight, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.83, RxSight, Inc. trades at 1.7x sales and 0.8x book value. Over the last twelve months it generated about $123M of revenue and a net loss of $54M. It runs a gross margin of 76.1%, an operating margin of -50.4% and a net margin of -43.8%. It shows return on equity of -20.1%, return on invested capital of -23.0% and a free cash flow yield of 9.2%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 4.20. Over the past 52 weeks the share price ranged from $4.11 to $13.22, with a beta of 1.19.
RxSight, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 3 Buy, 7 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.